{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:43:29Z","timestamp":1792734209210,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.tim.2010.02.001","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T09:42:14Z","timestamp":1267782134000},"page":"164-172","source":"Crossref","is-referenced-by-count":26,"title":["Gaining ground: assays for therapeutics against botulinum neurotoxin"],"prefix":"10.1016","volume":"18","author":[{"given":"Ramin Mollaaghababa","family":"Hakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Ruthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2010.02.001_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tim.2010.02.001_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tim.2010.02.001_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MMBR.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","volume":"56","author":"Schantz","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.tim.2010.02.001_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2005.06.012","article-title":"New insights into clostridial neurotoxin-SNARE interactions","volume":"11","author":"Breidenbach","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tim.2010.02.001_bib5","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1073\/pnas.0408526102","article-title":"Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk","volume":"102","author":"Wein","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2010.02.001_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.tim.2010.02.001_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03033931","article-title":"Botulinum neurotoxin - from laboratory to bedside","volume":"9","author":"Foster","year":"2006","journal-title":"Neurotox Res."},{"key":"10.1016\/j.tim.2010.02.001_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.coph.2009.03.004","article-title":"Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics","volume":"9","author":"Dolly","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tim.2010.02.001_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.parkreldis.2006.06.002","article-title":"Botulinum toxin: clinical use","volume":"12","author":"Truong","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.tim.2010.02.001_bib10","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1073\/pnas.0903111106","article-title":"Engineering botulinum neurotoxin to extend therapeutic intervention","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 4","key":"10.1016\/j.tim.2010.02.001_bib11","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1016\/j.vaccine.2009.08.059","article-title":"Botulism and vaccines for its prevention","volume":"27","author":"Smith","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2010.02.001_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ccc.2005.06.008","article-title":"Botulinum toxin","volume":"21","author":"Horowitz","year":"2005","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.tim.2010.02.001_bib13","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1007\/s00018-008-8088-0","article-title":"Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins","volume":"65","author":"Brunger","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.tim.2010.02.001_bib14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.200305098","article-title":"Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells","volume":"162","author":"Dong","year":"2003","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.tim.2010.02.001_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tim.2010.02.001_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0609713104","article-title":"Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept","volume":"104","author":"Rummel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2010.02.001_bib17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0022-3565(25)20272-5","article-title":"Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin","volume":"258","author":"Bakry","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tim.2010.02.001_bib18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.bmcl.2007.02.028","article-title":"Synthesis of soluble multivalent glycoconjugates that target the Hc region of botulinum neurotoxin A","volume":"17","author":"Kale","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tim.2010.02.001_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3565(25)33626-8","article-title":"Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins","volume":"225","author":"Simpson","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tim.2010.02.001_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-3565(25)38691-X","article-title":"Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins","volume":"269","author":"Simpson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tim.2010.02.001_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/bi0356698","article-title":"Uptake of botulinum neurotoxin into cultured neurons","volume":"43","author":"Keller","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.tim.2010.02.001_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tins.2005.06.007","article-title":"SNARE complexes prepare for membrane fusion","volume":"28","author":"Sorensen","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tim.2010.02.001_bib23","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1002\/anie.200705531","article-title":"The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison","volume":"47","author":"Willis","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tim.2010.02.001_bib24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.str.2008.07.011","article-title":"A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate","volume":"16","author":"Zuniga","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.tim.2010.02.001_bib25","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1021\/bi0477642","article-title":"Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity","volume":"44","author":"Schmidt","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.tim.2010.02.001_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-5793(98)01041-2","article-title":"Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1\u2019 binding subsite","volume":"435","author":"Schmidt","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tim.2010.02.001_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1399-3011.2004.00124.x","article-title":"Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease","volume":"63","author":"Sukonpan","year":"2004","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.tim.2010.02.001_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF03033940","article-title":"The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection","volume":"9","author":"Shone","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.tim.2010.02.001_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AEM.69.1.297-303.2003","article-title":"Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F","volume":"69","author":"Schmidt","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tim.2010.02.001_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1742-7843.2004.pto950503.x","article-title":"Inhibition of the protease activity of the light chain of type A botulinum neurotoxin by aqueous extract from stinging nettle (Urtica dioica) leaf","volume":"95","author":"Gul","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tim.2010.02.001_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/B:JOPC.0000005459.00492.60","article-title":"A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity","volume":"22","author":"Adler","year":"2003","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.tim.2010.02.001_bib32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/cbic.200400398","article-title":"Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity","volume":"6","author":"Anne","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.tim.2010.02.001_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2003.08.112","article-title":"Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity","volume":"310","author":"Burnett","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tim.2010.02.001_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-3565(24)38812-3","article-title":"Cleavage of intracellular substrates of botulinum toxins A, C and D in a mammalian target tissue","volume":"296","author":"Kalandakanond","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tim.2010.02.001_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/BJ20050855","article-title":"Synaptic vesicle chips to assay botulinum neurotoxins","volume":"391","author":"Ferracci","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.tim.2010.02.001_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.taap.2008.09.005","article-title":"A protein chip membrane-capture assay for botulinum neurotoxin activity","volume":"233","author":"Marconi","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tim.2010.02.001_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AEM.01690-07","article-title":"Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B and E","volume":"74","author":"Hines","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tim.2010.02.001_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/abio.2001.5028","article-title":"High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity","volume":"291","author":"Anne","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tim.2010.02.001_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1087057105278927","article-title":"Integrated bioassays in microfluidic devices: botulinum toxin assays","volume":"10","author":"Mangru","year":"2005","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.tim.2010.02.001_bib40","doi-asserted-by":"crossref","first-page":"14701","DOI":"10.1073\/pnas.0404107101","article-title":"Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells","volume":"101","author":"Dong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2010.02.001_bib41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.toxicon.2008.12.016","article-title":"Tandem fluorescent proteins as enhanced FRET-based substrates for botulinum neurotoxin activity","volume":"53","author":"Pires-Alves","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.tim.2010.02.001_bib42","doi-asserted-by":"crossref","first-page":"e2041","DOI":"10.1371\/journal.pone.0002041","article-title":"Attomolar detection of botulinum toxin type A in complex biological matrices","volume":"3","author":"Bagramyan","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tim.2010.02.001_bib43","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/AEM.00091-09","article-title":"Detection and quantification of botulinum neurotoxin type a by a novel rapid in vitro fluorimetric assay","volume":"75","author":"Poras","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tim.2010.02.001_bib44","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"Antibody protection against botulinum neurotoxin intoxication in mice","volume":"77","author":"Cheng","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2010.02.001_bib45","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/ac050485f","article-title":"From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry","volume":"77","author":"Boyer","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tim.2010.02.001_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ab.2006.01.027","article-title":"The use of Endopep-MS for the detection of botulinum toxins A, B, E and F in serum and stool samples","volume":"351","author":"Kalb","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tim.2010.02.001_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0958-1669(98)80141-9","article-title":"Intracellular detection assays for high-throughput screening","volume":"9","author":"Gonzalez","year":"1998","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.tim.2010.02.001_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10408410701364562","article-title":"Botulism diagnostics: from clinical symptoms to in vitro assays","volume":"33","author":"Cai","year":"2007","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.tim.2010.02.001_bib49","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1016\/j.febslet.2005.08.072","article-title":"Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A","volume":"579","author":"Eubanks","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tim.2010.02.001_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2004.02.011","article-title":"Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies","volume":"288","author":"Hall","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tim.2010.02.001_bib51","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.febslet.2007.08.078","article-title":"A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies","volume":"581","author":"Pellett","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tim.2010.02.001_bib52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"Foran","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tim.2010.02.001_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.toxicon.2004.11.009","article-title":"Primary cell culture for evaluation of botulinum neurotoxin antagonists","volume":"45","author":"Sheridan","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.tim.2010.02.001_bib54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1087057106299163","article-title":"Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: implications for therapeutic discovery","volume":"12","author":"Stahl","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.tim.2010.02.001_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1087057109354779","article-title":"Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies","volume":"15","author":"Nuss","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.tim.2010.02.001_bib56","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.0510816103","article-title":"A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate","volume":"103","author":"Fang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2010.02.001_bib57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.109.156901","article-title":"Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin A","volume":"331","author":"Thyagarajan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tim.2010.02.001_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejphar.2004.12.007","article-title":"Comparison of the therapeutic indexes of different molecular forms of botulinum toxin type A","volume":"508","author":"Yoneda","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tim.2010.02.001_bib59","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00141-09","article-title":"Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A","volume":"53","author":"Roxas-Duncan","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.tim.2010.02.001_bib60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.toxicon.2005.03.022","article-title":"Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle","volume":"46","author":"Dodd","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.tim.2010.02.001_bib61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","article-title":"Recovery from botulinum neurotoxin poisoning in vivo","volume":"139","author":"Keller","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.tim.2010.02.001_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026119290603400314","article-title":"Progress in applying the Three Rs to the potency testing of Botulinum toxin type A","volume":"34","author":"Straughan","year":"2006","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.tim.2010.02.001_bib63","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.toxicon.2008.06.021","article-title":"The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations","volume":"52","author":"Pickett","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.tim.2010.02.001_bib64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/78956","article-title":"Identifying conformational changes with site-directed spin labeling","volume":"7","author":"Hubbell","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.tim.2010.02.001_bib65","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1021\/bi991963h","article-title":"Time-resolved site-directed spin-labeling studies of bacteriorhodopsin: loop-specific conformational changes in M","volume":"39","author":"Mollaaghababa","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.tim.2010.02.001_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.7939627","article-title":"Time-resolved detection of structural changes during the photocycle of spin-labeled bacteriorhodopsin","volume":"266","author":"Steinhoff","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.tim.2010.02.001_bib67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/epr.09.2","article-title":"Protein microarrays: high-throughput tools for proteomics","volume":"6","author":"Stoevesandt","year":"2009","journal-title":"Expert Rev. Proteomics"}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X10000168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X10000168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:11:20Z","timestamp":1739927480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X10000168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0966842X10000168"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2010.02.001","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}